Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04334668 · ClinicalTrials.gov registry record · NA

Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure

A NA study of Volume Overload, sponsored by The Cleveland Clinic.

Active
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT04334668 is a NA study of Volume Overload that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 67 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04334668, a NA study of Volume Overload, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

The investigators are proposing a prospective, randomized, double blinded, placebo-controlled single center study evaluating the role of co-administration of oral sodium chloride (NaCl) with intravenous diuretics in patients hospitalized with acute decompensated heart failure. The investigators are approaching this study with the hypothesis that the use of oral sodium chloride leads to improved effective diuresis (as measured by weight loss) and renal function as compared to placebo in patients hospitalized with acute decompensated heart failure undergoing aggressive intravenous diuretic therapy.

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Oral Sodium Chloride

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2020-05-20
Est. Completion 2026-12-31
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT04334668

The ClinicalTrials.gov registry entry for NCT04334668 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Volume Overload appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04334668 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04334668 about?

NCT04334668 is a clinical study titled "Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure". The investigators are proposing a prospective, randomized, double blinded, placebo-controlled single center study evaluating the role of co-administration of oral sodium chloride (NaCl) with intravenous diuretics in patients hospitalized with acute decompensated heart failure. The investigators are ...

What is the current status of trial NCT04334668?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2020-05-20. Estimated completion is 2026-12-31.

What conditions does trial NCT04334668 study?

This clinical trial studies the following conditions: Volume Overload.

What interventions are being tested in trial NCT04334668?

The interventions under investigation include: Placebo (OTHER), Oral Sodium Chloride (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04334668?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04334668 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Volume Overload

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.